CN106360177A - Fruit drink and preparation method thereof - Google Patents
Fruit drink and preparation method thereof Download PDFInfo
- Publication number
- CN106360177A CN106360177A CN201610777995.1A CN201610777995A CN106360177A CN 106360177 A CN106360177 A CN 106360177A CN 201610777995 A CN201610777995 A CN 201610777995A CN 106360177 A CN106360177 A CN 106360177A
- Authority
- CN
- China
- Prior art keywords
- parts
- raw material
- fruit
- fructus
- mass parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013399 edible fruits Nutrition 0.000 title claims abstract description 47
- 238000002360 preparation method Methods 0.000 title abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 36
- 235000013361 beverage Nutrition 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 16
- 229960005070 ascorbic acid Drugs 0.000 claims description 14
- 239000003755 preservative agent Substances 0.000 claims description 8
- 230000002335 preservative effect Effects 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 235000017784 Mespilus germanica Nutrition 0.000 abstract description 13
- 235000000560 Mimusops elengi Nutrition 0.000 abstract description 13
- 235000007837 Vangueria infausta Nutrition 0.000 abstract description 13
- 230000000050 nutritive effect Effects 0.000 abstract description 5
- 240000002624 Mespilus germanica Species 0.000 abstract 3
- 244000189799 Asimina triloba Species 0.000 abstract 2
- 235000006264 Asimina triloba Nutrition 0.000 abstract 2
- 235000009467 Carica papaya Nutrition 0.000 abstract 2
- 235000021022 fresh fruits Nutrition 0.000 description 20
- 230000001954 sterilising effect Effects 0.000 description 19
- 238000004659 sterilization and disinfection Methods 0.000 description 14
- 244000182216 Mimusops elengi Species 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 9
- 239000004302 potassium sorbate Substances 0.000 description 9
- 235000010241 potassium sorbate Nutrition 0.000 description 9
- 229940069338 potassium sorbate Drugs 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 229920000157 polyfructose Polymers 0.000 description 5
- 229940045997 vitamin a Drugs 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 229920001202 Inulin Polymers 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 150000001746 carotenes Chemical class 0.000 description 3
- 235000005473 carotenes Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 3
- 229940029339 inulin Drugs 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010006242 Breast enlargement Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 240000001008 Dimocarpus longan Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 235000000235 Euphoria longan Nutrition 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000037180 bone health Effects 0.000 description 2
- 230000003559 chemosterilizing effect Effects 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical group C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000001473 noxious effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 239000003206 sterilizing agent Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QNTKVQQLMHZOKP-NEJDVEAASA-N (2r,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-2-[[(2r,3s,4s,5r)-2-[[(2r,3s,4s,5r)-2-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]- Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(O[C@@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QNTKVQQLMHZOKP-NEJDVEAASA-N 0.000 description 1
- RKUNBYITZUJHSG-FXUDXRNXSA-N (S)-atropine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 RKUNBYITZUJHSG-FXUDXRNXSA-N 0.000 description 1
- JECYNCQXXKQDJN-UHFFFAOYSA-N 2-(2-methylhexan-2-yloxymethyl)oxirane Chemical compound CCCCC(C)(C)OCC1CO1 JECYNCQXXKQDJN-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 description 1
- 241000033870 Citrullus lanatus subsp. vulgaris Species 0.000 description 1
- 235000012840 Citrullus vulgaris Nutrition 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 235000004237 Crocus Nutrition 0.000 description 1
- 241000596148 Crocus Species 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000004330 calcium propionate Substances 0.000 description 1
- 235000010331 calcium propionate Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- OPGYRRGJRBEUFK-UHFFFAOYSA-L disodium;diacetate Chemical compound [Na+].[Na+].CC([O-])=O.CC([O-])=O OPGYRRGJRBEUFK-UHFFFAOYSA-L 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- QNTKVQQLMHZOKP-UHFFFAOYSA-N fructofuranosylnystose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OCC2(OCC3(OC4C(C(O)C(O)C(CO)O4)O)C(C(O)C(CO)O3)O)C(C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 QNTKVQQLMHZOKP-UHFFFAOYSA-N 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229960003210 hyoscyamine Drugs 0.000 description 1
- 229930005342 hyoscyamine Natural products 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000001983 lactogenic effect Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 238000013048 microbiological method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- -1 sodium benzoate Chemical class 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000017454 sodium diacetate Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a fruit drink and a preparation method thereof. The fruit drink is prepared from the following raw materials in parts by mass: 45 to 65 parts of medlar, 25 to 45 parts of pawpaw and 1 to 10 parts of fructo-oligose. The fruit drink provided by the invention contains the raw materials such as the pawpaw and the medlar, which are compounded to enable the fruit drink to have a higher nutritive value. In addition, the medlar also enables the fruit drink to have a better health-care value.
Description
Technical field
The present invention relates to the technical field of beverage, in particular to a kind of fruit beverage and preparation method thereof.
Background technology
Nowadays, people start to like some teabag drink, and for example, black tea, green tea, milk tea or honey citron tea are all people
The beverage often selected, but, if things go on like this also can drink to obtain botheration, people still like having a change in diet.The appearance pole of fruit beverage
The earth has expanded the demand to drink variety for the people.
Also some fruit beverages are occurred in that in prior art.Protect as Chinese patent cn102960793a discloses a kind of fruit
Strong beverage, this fruit health beverage includes fruit protoplasm, Semen Phaseoli, Arillus Longan, Poria, each component ratio be 80～100 parts of fruit oleo stock,
6～8 parts of Semen Phaseoli, 3～5 parts of Arillus Longan, 5～8 parts of mixing post packages of Poria；Fruit oleo stock: sugar: water=300:10:200.Described water
Fruit protoplasm through squeezing, takes liquid, through Overheating Treatment, cooling and standing after filtration, is filtrated to get again for after fruit smashing.With
The method that fruice is directly prepared, creates the beverage new varieties with health care, maintains distinctive local flavor, also preferably
Maintain effective nutrition of fruit and fruit beverage additive is many, local flavor has unsatisfactory place, and body is had
Certain damage, this invention materials is natural, process is simple, comprehensive nutrition, and mouthfeel is unique.
In prior art, fruit beverage leads to its nutritive value relatively low due to containing only fruit.
Content of the invention
In view of this, one aspect of the present invention is to provide a kind of fruit beverage, and this fruit beverage has higher nutriture value
Value.
A kind of fruit beverage, its raw material comprises following components according to mass parts: 45～65 portions of Fructus Lyciis, 25～45 portions of Fructus Chaenomeliss and
1～10 part of oligofructose.
Further, its raw material also includes 0.1～0.5 part of vitamin c according to mass parts.
Further, its raw material also includes 0.1～0.3 portion of preservative according to mass parts.
Further, the mass parts of described Fructus Lycii are 50～60 portions of Fructus Lyciis.
Further, the mass parts of described Fructus Chaenomeliss are 30～40 parts.
Further, the mass parts of described oligofructose are 2～8 parts.
Further, its raw material comprises following components: 55 portions of Fructus Lyciis, 36 portions of Fructus Chaenomeliss and 5 parts of oligofructoses according to mass parts.
Further, the mass parts of described vitamin c are 0.3 part.
Further, the mass parts of described preservative are 0.2 part.
Another aspect of the invention is to provide a kind of manufacture method using such as above-mentioned fruit beverage, and this manufacture method obtains
Fruit beverage there is higher nutrition.
A kind of manufacture method as above-mentioned fruit beverage, each component mix homogeneously is formed.
The fruit beverage of the present invention, Fructus Chaenomeliss and Fructus Lycii that its raw material is comprised, Fructus Lycii and Fructus Chaenomeliss compound so that fruit
Beverage has higher nutritive value.Additionally, Fructus Lycii also makes fruit beverage have preferable health value.
Specific embodiment
For the ease of understanding the present invention, close embodiment below to further illustrate technical scheme.
As used herein, term:
" mass parts " refer to represent the basic measurement unit of the mass ratio relation of multiple components, 1 part can represent arbitrary list
Position quality, such as can be expressed as 1g, may also indicate that 2.689g etc..If we say that the mass parts of a component are a part, the matter of b component
Amount part is b part then it represents that mass ratio a:b of the quality of a component and b component.Or ground, represents that the quality of a component is ak, b
The quality of component is bk (k is Arbitrary Digit, represents multiplying factor).Can not misread, and unlike mass fraction, all groups
The mass parts sum divided is not limited to 100 parts of restriction.
" one ", " a kind of " and " described " are used interchangeably and refer to one or more.
"and/or" be used for representing one of illustrated situation or both of which it may happen that, for example, a and/or b includes (a
And b) and (a or b)；
In addition, included all numerical value (for example, 1 to 10 bag being comprised in the range of this herein by the scope that end points is stated
Include 1.4,1.9,2.33,5.75,9.98 etc.).
In addition, the statement of herein " at least one " include one and above all numbers (for example, at least 2, at least
4, at least 6, at least 8, at least 10, at least 25, at least 50, at least 100 etc.).
The fruit beverage of the present invention, its raw material comprises following components: 45～65 parts of Fructus Lyciis, 25～45 parts of wood according to mass parts
Melon and 1～10 part of oligofructose.
For example, the mass parts of Fructus Lycii can for 45 parts, 45.5 parts, 46 parts, 48 parts, 50 parts, 55 parts, 58 parts, 60 parts, 62
Part, 63 parts, 64 parts or 65 parts, preferably 50～60 parts, special standby preferably 55 parts.The mass parts of Fructus Chaenomeliss can for 25 parts, 26 parts,
28 parts, 30 parts, 32 parts, 35 parts, 38 parts, 40 parts, 42 parts, 43 parts, 44 parts or 45 parts etc., preferably 30～40 parts, particularly preferably
For 36 parts.The mass parts of oligofructose can for 1 part, 1.2 parts, 1.5 parts, 2 parts, 2.5 parts, 3 parts, 5 parts, 5.5 parts, 6 parts, 7 parts,
8 parts, 9 parts, 9.5 parts, 9.8 parts or 10 parts etc., preferably 2～8 parts, particularly preferably 5 parts etc..
Above-mentioned, Fructus Lycii can provide preferable nutritive value, is because that its calory burning is 258 (kilocalories), b1 thiamine
Content is 0.35 (milligram), calcium content is 60 milligrams, protein content is 13.9 milligrams, b2 core yellow cellulose content is 0.46 milligram,
Content of magnesium is 96 milligrams, fat content is 1.5 milligrams, b5 Nicotinic Acid Content is 4 milligrams, iron content is 5.4 milligrams, carbohydrate
Content is 47.2 milligrams, Determination of Vitamin C is 48 milligrams, manganese content is 0.87 milligram, dietary fiber content is 16.9 milligrams, dimension
Raw element e content is 1.86 milligrams, Zn content is 1.48 milligrams, Content of Vitamin A is 16.25 micrograms, cholesterol level is 0 milli
Gram, carotin content be 3.8 micrograms, potassium content be 434 milligrams, p phosphorus content be 209 milligrams, retinol equivalent be 16.7 micro-
Gram, sodium content be 252.1 milligrams, Se content be 13.25 micrograms.
In addition, Fructus Lycii can provide preferable health care shape, it is because: its main component is glycine betaine, atropine, hyoscyamine
Deng.Lycium barbarum polysaccharide has promotion immunity, defying age, antitumor, removes free radical, resisting fatigue, radioprotective, liver protection, reproductive function
The effect such as protection and improvement.To lipid metabolism or lipotropic effect, it plays the effect of methyl supplying to glycine betaine in vivo.
Contained wolfberry pigment mainly includes carotene, phylloxanthin and other coloring matters.Carotenoid contained by Fructus Lycii is then
There is very important medical value.Seed of Fructus Lycii pigment has raising immune function of human body, prevention and suppression tumor and prevention is dynamic
Pulse atherosclerosis etc. act on.Carotene is the main active of wolfberry pigment, has antioxidation and the conjunction as vitamin a
Become the important physiological functions such as precursor.
Fructus Lycii in the present invention is preferably medlar fresh fruit concentrated solution.Medlar fresh fruit concentrated solution refer to be squeezed the juice by medlar fresh fruit and
The concentration of juices liquid obtaining.
Above-mentioned Fructus Chaenomeliss can provide higher nutritive value, is because, its be rich in vitamin a, b1, b2, c, mineral ferrum,
Calcium, potassium, also contain natural plants " polysaccharide ", protein, Fructus Chaenomelis ferment and organic acid.In 17 kinds of aminoacid contained therein
Include whole essential amino acids, and ratio is close to human body protein；Phosphorus, potassium content are also higher；Vitamin a and vitamin
The content of c is especially high, is 5 times of Citrullus vulgariss and Fructus Musae.Contain abundant breast enlargement hormone and vitamin a in Fructus Chaenomelis ferment, female can be stimulated
Sex hormone is secreted, and stimulates ovarian secretion estrogen, makes mammary gland unimpeded, reaches breast enlargement purpose；Skin metabolism can also be promoted,
Help dissolve the sebum piled up in pore and aging cutin, allow skin seem brighter, more pure and fresh；Also decomposable asymmetric choice net protein, sugar
Class, decomposable asymmetric choice net fat, remove proud flesh, promote new metabolism, in time superabundant fats are excreted.Fructus Chaenomeliss contain carotene, this anti-
Oxidation material makes sarcocarp become crocus, and reduces the infringement that environmental pollution causes.Fructus Chaenomeliss are also rich in beta-carotene, and this is one
Plant natural antioxidant, be effective against the oxidation of systemic cell, destroy and make human body accelerate old and feeble oxygen-derived free radicals.Therefore,
Often eat effect that Fructus Chaenomeliss also have beauty and skin care, slow down aging.Fructus Chaenomeliss are also rich in vitamin c, contribute to repairing body tissue, eliminate
The noxious substance of infringement body cell, strengthens human disease resistance.Flavonoid substances in Fructus Chaenomeliss have obvious antioxidation and
Remove free radical, anticancer, blood pressure lowering and blood fat reducing, improve the effect such as microcirculation, antibacterial, antiinflammatory.Also there is stable blood vessel and capillary
Tubular elastic, increases arterial flow, arrhythmia, antiulcer etc. acts on.May additionally facilitate estrogen hormone secretion, promote breast
Gland conduit is developed and hypertrophy is full.
Additionally, Fructus Chaenomeliss may also provide higher health value, it is because: it has strengthening the spleen and stomach, aid digestion, alcoholic intoxication, fall
The effects such as blood pressure, lactogenic, removing toxic substances and promoting subsidence of swelling, relieving constipation anthelmintic, can help treat dyspepsia, gastritis stomachache, duodenal ulcer,
The diseases such as angina pectoriss, hypertension, vitamin C deficiency, puerpera's hypogalactia.
Fructus Chaenomeliss in the present invention can adopt Fructus Chaenomeliss fresh fruit concentrated solution.Here, Fructus Chaenomeliss fresh fruit concentrated solution refers to by Fructus Chaenomeliss fresh fruit
Concentration of juices liquid obtained from squeezing the juice.
Above-mentioned, oligofructose, also known as fructooligosaccharide, is to be passed through in β (2-1) glycosidic bond and sucrose by 1～3 fructosyl
Fructosyl combine the mixture of the ketose generating, C24H42 O21 and Fructofuranosyl nystose etc..In the present invention, oligofructose can be made
For a kind of sweeting agent, to reach the effect of low-sugar and low-heat value.In addition, oligofructose also has the effect of following health nutrient: 1,
Because oligofructose directly can not be digested and assimilated by human body, can only be absorbed by intestinal bacteria, therefore its calorific value is low, is not result in
Obesity, also has antiobesity action indirectly；2nd, because it can not be utilized by oral cavity bacterium (referring to streptococcus mutans smutans), thus tool
Anti-caries are had to act on；3rd, the proliferation function to intestinal beneficial bacteria.Oligofructose is to profitable strain in intestinal such as bifidus bacilluss, lactic acid bar
The selective proliferation function such as bacterium, makes profitable strain take advantage in intestinal, the growth of suppression harmful bacteria, reduces noxious substance
The formation of (as endotoxin, Ammonia etc.), has protective effect to intestinal mucosa cells regulating liver-QI, thus preventing the generation of pathological changes intestinal cancer,
Enhancing human body immunity power；4th, cholesterol in serum and the content of triglyceride can be reduced；5th, the absorption of nutrition, especially calcium are promoted
Absorption.Take in oligofructose and can improve the absorption to calcium ion for the organism, this phenomenon is of increased attention, one
A little human clinical trial are also carried out successively.For teenager, the inulin containing abundant oligofructose confirms can be by strengthening
The calcium absorption and increase bone density effectiveness to bone health generation front.For the women after menolipsis, rich in oligofructose
Inulin confirms to improve mineral absorption and improve bone health.In addition, supplement the inulin containing abundant oligofructose can help
Improve the mineral absorption of climacteric women and affect its bone update mark；6th, preventing and treating diarrhoea and constipation.
The fruit beverage of the present invention may also include 0.1～0.5 part of vitamin c, and the mass parts of such as vitamin c can be
0.1 part, 0.12 part, 0.15 part, 0.2 part, 0.3 part, 0.4 part, 0.45 part, 0.47 part, 0.48 part, 0.49 part or 0.50 part, excellent
Elect 0.3 part as.
The fruit beverage of the present invention may also include 0.1～0.3 portion of preservative.For example, the mass parts of preservative can be 0.1
Part, 0.12 part, 0.15 part, 0.2 part, 0.25 part, 0.27 part, 0.28 part, 0.29 part or 0.30 part, preferably 0.2 part.
Here, preservative Main Function is growth and the breeding of suppression microorganism, to extend the holding time of food, suppression
The corrupt medicament of material.Preservative can adopt benzoic acid and its esters, such as sodium benzoate, or sorbic acid and its esters, such as mountain
Potassium sorbate, or dehydroactic acid and sodium salt, or parabenses, such as methyl parahydroxybenzoate, ethyl ester, propyl ester, butyl ester
Deng, or sodium diacetate, calcium propionate, sodium lactate etc..It is preferably potassium sorbate.
The manufacture method of fruit beverage of the present invention, each component mix homogeneously is formed.Here the mode mixing is not made especially
Restriction.
Can be sterilized after above-mentioned mixing.Sterilization no longer can be described in detail in this by the way of routine.Can include
Radiation sterilization, gaseous sterilization, filtration sterilization method, the mode of ultraviolet sterilization.Radiation sterilization refers to Cordyceps raw material subject to sterilization and puts
Enter to carry out ionizing radiation in the electricity that suitable radiation gamma-rays of source radiation or suitable electricity accelerator occurs bundle and reach and kill
The method of microorganism killing.The more conventional 60co- gamma-rays of this method.The gas that gaseous sterilization chemosterilant is formed is killed micro-
Biological method.Conventional chemosterilant has oxirane, gaseous hydrogen peroxide, formaldehyde, ozone etc., is conveniently here
Ozone sterilization.Ozone sterilization is the strong oxidizing property using ozone, 3 kinds of forms below its mechanism: 1, ozone energy oxidation Decomposition antibacterial
Enzyme needed for endogenous glucose, makes bacteria inactivation dead.2nd, directly with antibacterial, virus function, destroy their organelle with
Dna, rna, make the metabolism of antibacterial be subject to broken field, lead to bacterial death.3rd, pass through cell membrane tissue, invade intracellular, make
Lipoprotein for adventitia and internal lipopolysaccharide, make antibacterial occur penetrating sex distortion to dissolve death.Filtration sterilization method is profit
The method that microorganism in gas or liquid can not be removed by the principle of fine and close tool air filter material with antibacterial.It is usually used in thermally labile
Drug solution or raw material degerming.Ultraviolet disinfection is to kill various microorganisms using ultraviolet, and penetrates air and to thing
The strong feature of product surface sterilization ability.Ultraviolet disinfection can be adopted as, based on simple to operate, safe purpose
The present invention does not address part and is applied to prior art.
The specific embodiment of the present invention is given below, but specific embodiment is merely to be described in further detail this explanation,
It is not intended to limit the claims of the present patent application.
Embodiment 1
Step one, according to proportion by weight raw material: 45 parts of medlar fresh fruit concentrated solutions, 25 parts of Fructus Chaenomeliss fresh fruit concentrated solutions, 1 part low
Polyfructose., 0.1 part of vitamin c and 0.1 part of potassium sorbate.
Step 2, by raw material mix homogeneously.
Step 3, the raw material after Titian is carried out sterilizing, packs.
Embodiment 2
Step one, according to proportion by weight raw material: 65 parts of medlar fresh fruit concentrated solutions, 45 parts of Fructus Chaenomeliss fresh fruit concentrated solutions, 1 part low
Polyfructose., 0.1 part of vitamin c and 0.1 part of potassium sorbate.
Step 2, by raw material mix homogeneously.
Step 3, the raw material after Titian is carried out sterilizing, packs.
Embodiment 3
Step one, according to proportion by weight raw material: 45 parts of medlar fresh fruit concentrated solutions, 45 parts of Fructus Chaenomeliss fresh fruit concentrated solutions, 10 parts
Oligofructose, 0.5 part of vitamin c and 0.3 part of potassium sorbate.
Step 2, by raw material mix homogeneously.
Step 3, the raw material after Titian is carried out sterilizing, packs.
Embodiment 4
Step one, according to proportion by weight raw material: 60 parts of medlar fresh fruit concentrated solutions, 40 parts of Fructus Chaenomeliss fresh fruit concentrated solutions, 8 parts low
Polyfructose., 0.1 part of vitamin c and 0.1 part of potassium sorbate.
Step 2, by raw material mix homogeneously.
Step 3, the raw material after Titian is carried out sterilizing, packs.
Embodiment 5
Step one, according to proportion by weight raw material: 50 parts of medlar fresh fruit concentrated solutions, 30 parts of Fructus Chaenomeliss fresh fruit concentrated solutions, 2 parts low
Polyfructose., 0.1 part of vitamin c and 0.1 part of potassium sorbate.
Step 2, by raw material mix homogeneously.
Step 3, the raw material after Titian is carried out sterilizing, packs.
Embodiment 6
Step one, according to proportion by weight raw material: 55 parts of medlar fresh fruit concentrated solutions, 36 parts of Fructus Chaenomeliss fresh fruit concentrated solutions, 5 parts low
Polyfructose., 0.3 part of vitamin c and 0.2 part of potassium sorbate.
Step 2, by raw material mix homogeneously.
Step 3, the raw material after Titian is carried out sterilizing, packs.
Embodiment 7
Step one, according to proportion by weight raw material: 55 parts of medlar fresh fruit concentrated solutions, 36 parts of Fructus Chaenomeliss fresh fruit concentrated solutions, 5.5 parts
Oligofructose, 0.5 part of vitamin c and 0.1 part of potassium sorbate.
Step 2, by raw material mix homogeneously.
Step 3, the raw material after Titian is carried out sterilizing, packs.
The fruit beverage of the present invention, capable of direct drinking, each one bottle sooner or later.
The fruit beverage shelf-life of the present invention: 24 months.Storage proceduress: deposit at shady and cool drying, it is to avoid direct sunlight,
Avoid freezing
The nutritional labeling of the fruit beverage of the present invention is as follows:
Numerical range due to involved each technological parameter in the present invention can not possibly all embody in the above-described embodiments,
As long as but the completely envisioned any numerical value falling in this numerical range above-mentioned of those skilled in the art all can implement this
Invention, also includes the combination in any of occurrence in the range of some numerical value certainly.Herein, for the consideration of length, eliminate to
Go out the embodiment of occurrence in certain one or more numerical range, the disclosure that this is not to be construed as technical scheme is not filled
Point.
Applicant states, the present invention illustrates detailed process equipment and the technological process of the present invention by above-described embodiment,
But the invention is not limited in above-mentioned detailed process equipment and technological process, that is, do not mean that the present invention has to rely on above-mentioned detailed
Process equipment and technological process could be implemented.Person of ordinary skill in the field it will be clearly understood that any improvement in the present invention,
The interpolation of the equivalence replacement to each raw material of product of the present invention and auxiliary element, concrete mode selection etc., fall in the protection of the present invention
In the range of.
Claims (10)
1. a kind of fruit beverage is it is characterised in that its raw material comprises following components according to mass parts: 45～65 portions of Fructus Lyciis, 25～
45 portions of Fructus Chaenomeliss and 1～10 part of oligofructose.
2. fruit beverage according to claim 1 is it is characterised in that its raw material also includes 0.1～0.5 part according to mass parts
Vitamin c.
3. fruit beverage according to claim 1 is it is characterised in that its raw material also includes 0.1～0.3 part according to mass parts
Preservative.
4. fruit beverage according to claim 1 is it is characterised in that the mass parts of described Fructus Lycii are 50～60 portions of Fructus Lyciis.
5. fruit beverage according to claim 1 is it is characterised in that the mass parts of described Fructus Chaenomeliss are 30～40 parts.
6. fruit beverage according to claim 1 is it is characterised in that the mass parts of described oligofructose are 2～8 parts.
7. fruit beverage according to claim 1 is it is characterised in that its raw material comprises following components according to mass parts: 55
Part Fructus Lycii, 36 portions of Fructus Chaenomeliss and 5 parts of oligofructoses.
8. fruit beverage according to claim 2 is it is characterised in that the mass parts of described vitamin c are 0.3 part.
9. fruit beverage according to claim 1 is it is characterised in that the mass parts of described preservative are 0.2 part.
10. a kind of manufacture method of fruit beverage as claimed in claim 1 is it is characterised in that form each component mix homogeneously.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610777995.1A CN106360177A (en) | 2016-08-30 | 2016-08-30 | Fruit drink and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610777995.1A CN106360177A (en) | 2016-08-30 | 2016-08-30 | Fruit drink and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106360177A true CN106360177A (en) | 2017-02-01 |
Family
ID=57901331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610777995.1A Pending CN106360177A (en) | 2016-08-30 | 2016-08-30 | Fruit drink and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106360177A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1389130A (en) * | 2002-07-16 | 2003-01-08 | 李旭常 | Mutritious herb tea and its making process |
| CN1759757A (en) * | 2005-10-17 | 2006-04-19 | 翁维健 | Mixed concentrated fruit juice, preparation method and application |
| CN101073433A (en) * | 2007-06-22 | 2007-11-21 | 上海新康制药厂 | Blackthorn pear fruit-juice solid product and its production |
| CN104664506A (en) * | 2015-03-16 | 2015-06-03 | 河南师范大学 | Multifunctional active lactobacillus-fermented compound fruit and vegetable juice drink and preparation method |
| CN106107272A (en) * | 2016-06-29 | 2016-11-16 | 明光市晶鑫饮料食品有限公司 | A kind of Chinese medicine blueberry juice drink |
-
2016
- 2016-08-30 CN CN201610777995.1A patent/CN106360177A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1389130A (en) * | 2002-07-16 | 2003-01-08 | 李旭常 | Mutritious herb tea and its making process |
| CN1759757A (en) * | 2005-10-17 | 2006-04-19 | 翁维健 | Mixed concentrated fruit juice, preparation method and application |
| CN101073433A (en) * | 2007-06-22 | 2007-11-21 | 上海新康制药厂 | Blackthorn pear fruit-juice solid product and its production |
| CN104664506A (en) * | 2015-03-16 | 2015-06-03 | 河南师范大学 | Multifunctional active lactobacillus-fermented compound fruit and vegetable juice drink and preparation method |
| CN106107272A (en) * | 2016-06-29 | 2016-11-16 | 明光市晶鑫饮料食品有限公司 | A kind of Chinese medicine blueberry juice drink |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102488122B (en) | Black tea fungus jelly and preparation method thereof | |
| CN103564591B (en) | Preparation method of zinc-rich barley seedling green beverage | |
| CN104686883A (en) | Bee pollen for protecting liver and enhancing human immunity and preparation method thereof | |
| KR20160058389A (en) | Method of Manufacturing Volumizing Antocyanine Probiotics Metabolite and Pharmetics, cosmetics and Juice and food complex | |
| CN102228103A (en) | Lemon and chrysanthemum tea beverage and preparation method thereof | |
| CN105176784A (en) | Appetite promoting mango enzyme vinegar and preparation method thereof | |
| CN107594109A (en) | A kind of pet drinks enzyme liquid and preparation method thereof | |
| CN105384562A (en) | Pleurotus geesteranus medium | |
| CN105146658B (en) | Local flavor enzyme beverage and preparation method thereof | |
| CN110419654A (en) | A kind of compound juice beverage and its production technology | |
| CN104522450A (en) | Corn oligopeptide pollen and preparation method thereof | |
| CN106889389A (en) | A kind of wild white bur oral liquid and preparation method thereof | |
| CN106578800A (en) | Sesame-flavour abelmoschus esculentus beverage and production method thereof | |
| CN108850758A (en) | A kind of preparation method of the fructus lycii enzyme beverage with anti-fatigue effect | |
| CN101972019B (en) | Facial beautification and health care function beverage made of radix polygonati officinalis and production method thereof | |
| CN110408504A (en) | A kind of production method of lime tree honey indigo fruit wine | |
| CN105325823A (en) | Kwas chlebowy drink and preparation method thereof | |
| CN102311909A (en) | Preparation method of watermelon fruit vinegar containing citrulline and propolis | |
| CN106360177A (en) | Fruit drink and preparation method thereof | |
| CN104686884A (en) | Bee pollen containing corn oligopeptide and preparation method of bee pollen | |
| CN104172338A (en) | Celery juice health beverage | |
| JP3762364B2 (en) | Health food production method using earthworms and ants | |
| CN109673994B (en) | Sour papaya and chili jam and preparation method thereof | |
| CN106418498A (en) | Method for preparing enzyme by using lemons and galangal as main materials | |
| KR101327802B1 (en) | Fermented extract of eel and manufacturing process of the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170201 |
|
| RJ01 | Rejection of invention patent application after publication |